UBS Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.7M Sell
580,793
-78,503
-12% -$10.2M 0.01% 1505
2025
Q4
$80.2M Sell
659,296
-196,767
-23% -$24.7M 0.02% 1188
2025
Q3
$96.1M Buy
856,063
+379,925
+80% +$44.5M 0.02% 1052
2025
Q2
$63.8M Sell
476,138
-265,197
-36% -$29.1M 0.01% 1294
2025
Q1
$49.9M Buy
741,335
+151,093
+26% +$10.4M 0.01% 1485
2024
Q4
$36.8M Buy
590,242
+530,990
+896% +$49.4M 0.01% 1735
2024
Q3
$9.3M Buy
59,252
+26,841
+83% +$4.14M ﹤0.01% 2441
2024
Q2
$4.88M Sell
32,411
-12,788
-28% -$1.53M ﹤0.01% 2898
2024
Q1
$3.34M Buy
45,199
+4,936
+12% +$407K ﹤0.01% 3400
2023
Q4
$3.18M Buy
40,263
+16,309
+68% +$984K ﹤0.01% 3296
2023
Q3
$1.31M Buy
23,954
+20,904
+685% +$1.5M ﹤0.01% 3849
2023
Q2
$256K Sell
3,050
-11,286
-79% -$864K ﹤0.01% 5315
2023
Q1
$1.09M Buy
14,336
+4,472
+45% +$309K ﹤0.01% 4033
2022
Q4
$609K Buy
9,864
+6,786
+220% +$361K ﹤0.01% 4531
2022
Q3
$128K Sell
3,078
-576
-16% -$25.1K ﹤0.01% 5495
2022
Q2
$115K Sell
3,654
-9,989
-73% -$266K ﹤0.01% 5315
2022
Q1
$367K Sell
13,643
-11,692
-46% -$209K ﹤0.01% 4915
2021
Q4
$486K Buy
25,335
+22,310
+738% +$559K ﹤0.01% 5010
2021
Q3
$100K Buy
3,025
+675
+29% +$20.6K ﹤0.01% 5832
2021
Q2
$78K Sell
2,350
-1,199
-34% -$33.2K ﹤0.01% 6072
2021
Q1
$148K Sell
3,549
-5,729
-62% -$176K ﹤0.01% 5674
2020
Q4
$184K Buy
9,278
+1,548
+20% +$22.9K ﹤0.01% 5290
2020
Q3
$106K Sell
7,730
-5,888
-43% -$101K ﹤0.01% 5146
2020
Q2
$244K Sell
13,618
-896
-6% -$14K ﹤0.01% 4661
2020
Q1
$175K Sell
14,514
-8,330
-36% -$140K ﹤0.01% 4824
2019
Q4
$434K Buy
22,844
+11,348
+99% +$208K ﹤0.01% 4961
2019
Q3
$273K Buy
11,496
+4,700
+69% +$113K ﹤0.01% 5015
2019
Q2
$197K Buy
+6,796
New +$186K ﹤0.01% 4925

Other funds holding TMDX